Clinical Trials
2
Active:0
Completed:2
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the "Surveillance")
Completed
- Conditions
- Heart Valve Disease
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- corlife
- Target Recruit Count
- 144
- Registration Number
- NCT02527629
- Locations
- 🇧🇪
Universitair Ziekenhuis Leuven, UZL, Leuven, Belgium
🇩🇪University of Düsseldorf, Department of Cardiovascular Surgery, Düsseldorf, Germany
🇩🇪Hannover Medical School, Hannover, Germany
European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR
Completed
- Conditions
- Heart Valve Disease
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- corlife
- Target Recruit Count
- 121
- Registration Number
- NCT02035540
- Locations
- 🇧🇪
Universitair Ziekenhuis Leuven, UZL, Leuven, Belgium
🇫🇷Université Paris Descartes, UPD, Paris, France
🇩🇪Hannover Medical School, Hannover, Germany
News
Lifeward Partners with CorLife to Expand Workers' Compensation Access to ReWalk Exoskeleton
Lifeward and CorLife have finalized an agreement making CorLife the exclusive distributor of the ReWalk Personal Exoskeleton for individuals with workers' compensation claims.